European CGM Accuracy Standard and New In‑Hospital and Pregnancy Guidance Push Diabetes Tech Forward
A new continuous glucose monitoring (CGM) system has become the first to meet a proposed European accuracy standard [1]. An international position statement offers practical guidance for using CGM, insulin pumps and automated insulin delivery (AID) in hospitals [3], and researchers call for AID studies in pregnant women with type 1 diabetes [2].
Key takeaways
- A CGM device now satisfies a formal European clinical performance benchmark for accuracy [1].
- An international guideline outlines how hospitals can safely adopt CGM, pumps and AID for non‑critical adult patients [3].
- Experts urge inclusion of pregnant women with type 1 diabetes in AID trials because current data are scarce [2].
European accuracy milestone
For the first time, a commercial system was shown to meet the European clinical performance criteria in a formal study [1]. The researchers measured how closely the sensor’s glucose readings matched reference blood glucose values and found the device stayed within the required error limits [1].
Hospital use gets a playbook
An international position statement now offers a practical framework for using CGM, insulin pumps and AID in non‑critical inpatient settings [3]. The document covers which patients are suitable, how to set CGM alarm thresholds for low and high glucose, and how to integrate device data into electronic health records [3]. It also details peri‑operative considerations, staff training needs, and discharge planning [3].
Pregnancy remains a research gap
Data specific to pregnancy are extremely limited [2]. A recent commentary calls for three actions: include pregnant women in clinical trials of new AID technologies, design AID algorithms that address the unique glucose swings of pregnancy, and support real‑world studies of currently approved AID systems while waiting for pregnancy‑specific innovations [2].
